Olopatadine Hydrochloride: Uses, Dosage, Side Effects | MedexInfo
Olopatadine Hydrochloride
Rx Only
Therapeutic ClassAntihistamine (H1 receptor antagonist)
Common Dose1 drop in affected eye(s) twice daily (0.1–0.2%)
Max / 24h2 drops per eye
PregnancyCategory C
Indications ▼
Allergic conjunctivitis: relief of ocular itching, redness, and tearing.
Seasonal allergic rhinitis: alleviates nasal itching, sneezing, and runny nose.
Perennial allergic rhinitis: symptom control for year-round allergic triggers.
Prevention of ocular allergy symptoms prior to allergen exposure (prophylactic use).
Adjunct therapy for patients not responding fully to topical antihistamines alone.
Mechanism & Pharmacokinetics ▼
Mechanism: Olopatadine is a selective H1 receptor antagonist with mast cell stabilizing activity. It inhibits the release of histamine and other inflammatory mediators from conjunctival mast cells, reducing itching, redness, and swelling.
Pharmacokinetics: After ocular administration, systemic absorption is minimal. Peak plasma concentration occurs within 10–15 minutes. Metabolized in the liver and excreted primarily via urine. Half-life ~8–12 hours. Minimal systemic side effects due to topical application.
Dosage & Administration ▼
| Patient Category | Recommended Dose | Max / 24h |
|---|---|---|
| Adults & Children ≥3 years | 1 drop in affected eye(s) twice daily (0.1–0.2%) | 2 drops per eye |
| Children <3 years | Not recommended | – |
Side Effects ▼
Common: mild burning or stinging on instillation, eye irritation, headache
Occasional: dry eyes, blurred vision, taste perversion (nasal spray)
Rare: hypersensitivity reactions including eyelid swelling, rash, or urticaria
Contraindications ▼
Hypersensitivity to olopatadine or any component of the formulation
Ocular infection (active bacterial, viral, or fungal infection) should be treated separately
Drug Interaction ▼
No clinically significant drug interactions reported with topical use
Concurrent use with other topical ophthalmic medications may reduce absorption; separate by at least 5 minutes
Pregnancy & Lactation ▼
Use only if clearly needed (Category C)
Minimal systemic absorption; generally considered compatible with breastfeeding
Clinical / Research Summary ▼
Ocular Allergy Symptom Relief: Multiple randomized controlled trials demonstrate that olopatadine 0.1–0.2% ophthalmic solution effectively reduces itching, redness, and tearing within 3–5 minutes, with sustained effect for up to 12 hours.
Mast Cell Stabilization: Clinical studies show that olopatadine stabilizes conjunctival mast cells, reducing histamine release and preventing recurrence of allergic symptoms upon repeated allergen exposure.
Comparative Effectiveness: Trials indicate olopatadine is at least as effective as ketotifen and azelastine ophthalmic solutions, with fewer burning sensations and better tolerability.
Safety Profile: Well-tolerated in long-term use, minimal systemic absorption reduces the risk of systemic side effects. Rare cases of hypersensitivity reported in post-marketing surveillance.
Nasally Administered Form: Olopatadine nasal spray has been shown in controlled trials to reduce sneezing, rhinorrhea, and nasal itching in seasonal allergic rhinitis, with rapid onset within 30–60 minutes and minimal systemic exposure.
Pharmacogenomic Considerations: Current evidence shows minimal variability in response due to CYP450 metabolism because of low systemic absorption; dosing adjustment generally unnecessary.
Patient Counseling Points ▼
Wash hands before and after applying eye drops
Avoid touching dropper tip to eye or other surfaces
Do not wear contact lenses during instillation; may resume 15 minutes after use
Do not exceed recommended dose; adherence ensures maximal symptom relief
Seek medical advice if eye irritation worsens, infection develops, or symptoms persist beyond 2 weeks
Storage & Handling ▼
Store at 2–25°C; avoid freezing or exposure to sunlight
Keep out of reach of children
Brand Names (Bangladesh & Global) ▼
Pataday
Opatanol
Olopad
Pataday
Opatanol
Patanol
Olopatadine HCl
Medical Disclaimer: This clinical summary is for informational purposes only. Always follow guidance from a qualified healthcare professional for dosage, interactions, and use.
.png)
